<DOC>
	<DOCNO>NCT00377000</DOCNO>
	<brief_summary>Evaluate patient preference factor compare two clindamycin/benzoyl peroxide gel . One dispense pump presentation , tube presentation .</brief_summary>
	<brief_title>A Pilot , Multi-Center , Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels .</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . INCLUSION CRITERIA : 1 . Patients clinical diagnosis acne vulgaris mild moderate severity 2 . Females childbearing potential , addition negative urine pregnancy test Visit 1 , must willing use acceptable form birth control study . 3 . Patients 18 year age old must provide Institutional Review Board ( IRB ) approve write informed consent . Patients 18 year age must IRB approve write informed consent parent legal guardian . Patients 12 17 year age must complete IRB approve assent form minor . 4 . Patients must willing able understand requirement study , abide restriction , apply medication instruct , return require study visit . 5 . Patients must good health free clinically significant disease , acne vulgaris , might interfere study evaluation . 6 . Patients use makeup must use brand makeup minimum period 2 week prior Baseline agree change makeup brand type study . EXCLUSION CRITERIA : 1 . Patients pregnant , nursing , plan pregnancy within study period . 2 . Patients 2 nodulocystic lesion face , exclude nose . 3 . Patients know hypersensitivity ingredient test product include clindamycin benzoyl peroxide . 4 . Patients treated prescription and/or overthecounter topical product , procedure perform may impact study assessment . 5 . Patients systemic dermatological disorder potential interfere evaluation ( e.g. , rosacea , seborrheic dermatitis , perioral dermatitis , corticosteroidinduced acne vulgaris , carcinoid syndrome , mastocytosis , acneform eruption cause medication , facial psoriasis , facial eczema , etc. ) . 6 . Patients clinically significant unstable medical disorder , lifethreatening disease , current malignancy . 7 . Patients engage activity involve excessive prolonged exposure sunlight . 8 . Patients consume excessive amount alcohol , abuse drug , condition would compromise compliance protocol . 9 . Patients treat investigational drug investigational device within period 30 day prior study entry . 10 . Alcoholic toner , astringent , medicate topical preparation ( prescription overthecounter ) , medicate makeup facial treatment area . 11 . Abrasive cleanser wash facial area . 12 . New cosmetic , new cleanser apply face . 13 . Patients must wear makeup visit , interfere evaluation . 14 . Patients use sauna within 48 hour prior visit .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>